
Arjan Diepstra
dr.
As a hematopathologist, I work on diagnostics of all types of hematological malignancies using a comprehensive panel of different techniques. Moreover, my main research interest involves Hodgkin lymphoma, with a strong focus on interactions between tumor cells and the microenvironment. In addition, I also have a long standing interest in genetic susceptibility. My areas of expertise are: immunology, tumor cell biology, genetic association studies and molecular diagnostics in pathology. I actively participate in international (EORTC) and national (HOVON) clinical trials.
Latest publications
(217)
Activities
(38)
Press/Media
(7)
Prizes
(4)
Datasets
(1)
Supervised work
(12)
Plasma symmetric dimethylarginine and kidney graft function in kidney transplant recipients
Published in: Nephrology Dialysis Transplantation
Access to document
10.1093/ndt/gfae109
document
TransplantLines Investigators, Daan Kremer, Sovia Salamah, Dion Groothof, Adrian Post, Tim J. Knobbe, António W.Gomes Neto, Sarah Peterson, Marco van Londen, Murthy Yerramilli, Stefan P. Berger, Firas F. Alkaff, Martin H. De Borst, Stephan J.L. Bakker
Calciprotein particle counts associate with vascular remodelling in chronic kidney disease
Published in: Cardiovascular Research
Access to document
10.1093/cvr/cvae164
document
AIMS: Calciprotein particles (CPPs) are circulating calcium and phosphate nanoparticles associated with development of vascular calcification (VC) in chronic kidney disease (CKD). Although recent studies have been focusing on associations of CPPs with presence of VC in CKD, insights in the underlying processes and mechanisms by which CPPs might aggravate VC and vascular dysfunction in vivo are currently lacking. Here, we assessed overall burden of abdominal VC in healthy kidney donors and CKD patients, and subsequently performed transcriptome profiling in vascular tissue obtained from these subjects, linking outcome...
TransplantLines Investigators, Lian Feenstra, Melanie Reijrink, Andreas Pasch, Edward R Smith, Lotte M Visser, Marian Bulthuis, Monique E Lodewijk, Mirjam F Mastik, Marcel J W Greuter, Riemer H J A Slart, Douwe J Mulder, Robert A Pol, Charlotte A te Velde-Keyzer, Guido Krenning, Jan-Luuk Hillebrands
Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients
Published in: American Journal of Transplantation
Access to document
10.1016/j.ajt.2024.03.017
document
Kidney transplant recipients (KTRs) experience more fatigue, anxiety, and depressive symptoms and lower concentration and health-related quality of life (HRQoL) compared with the general population. Anemia is a potential cause that is well-recognized and treated. Iron deficiency, however, is often unrecognized, despite its potential detrimental effects related to and unrelated to anemia. We investigated the interplay of anemia, iron deficiency, and patient-reported outcomes in 814 outpatient KTRs (62% male, age 56 ± 13 years) enrolled in the TransplantLines Biobank and Cohort Study (Groningen, The Netherlands). In total, 28%...
TransplantLines Investigators, Daan Kremer, Tim J. Knobbe, Joanna Sophia J. Vinke, Dion Groothof, Adrian Post, Coby Annema, Alferso C. Abrahams, Brigit C. van Jaarsveld, Martin H. de Borst, Stefan P. Berger, Stephan J.L. Bakker, Michele F. Eisenga
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry
Published in: -
Access to document
10.1182/bloodadvances.2023012531
document
Optimal treatment in patients with refractory or relapsed peripheral T-cell lymphomas (R/R T-NHLs) is unknown. In this population-based study, outcomes in R/R peripheral T-cell lymphoma not otherwise specified (PTCL NOS), angioimmunoblastic T-cell lymphoma (AITL), and anaplastic lymphoma kinase-positive (ALK+) and ALK-negative (ALK-) anaplastic large cell lymphoma (ALCL) were evaluated. Patients with PTCL NOS, AITL, ALK+ ALCL, and ALK- ALCL (≥18 years) diagnosed in 2014 to 2019 were identified using the Netherlands Cancer Registry. End points were overall response rate (ORR), progression-free survival (PFS), and overall survival (OS). The...
Mirian Brink, Francien Huisman, Frederik O Meeuwes, Marjolein W M van der Poel, Marie José Kersten, Mariëlle Wondergem, Lara Böhmer, F J Sherida H Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M Jansen, Arjan Diepstra, Tjeerd J F Snijders, Gerwin Huls, Joost S P Vermaat, Wouter J Plattel, Marcel Nijland
Memory B-cell derived donor-specific antibodies do not predict outcome in sensitized kidney transplant recipients: a retrospective single-center study
Published in: Frontiers in Immunology
Access to document
10.3389/fimmu.2024.1360627
document
BACKGROUND: Repeated exposure to sensitizing events can activate HLA-specific memory B cells, leading to the production of donor-specific memory B cell antibodies (DSAm) that pose a risk for antibody-mediated rejection (ABMR) in kidney transplant recipients (KTRs). This single-center retrospective study aimed to identify DSAm and assess their association with outcomes in a cohort of KTRs with pretransplant serum donor-specific antibodies (DSA). METHODS: We polyclonally activated pretransplant peripheral blood mononuclear cells (PBMCs) from 60 KTRs in vitro, isolated and quantified IgG from the culture supernatant using ELISA, and analyzed...
Dania Altulea, Joost C van den Born, Arjan Diepstra, Laura Bungener, Dagmar Terpstra, Bouke G Hepkema, Rosa Lammerts, Peter Heeringa, Sebastiaan Heidt, Henny Otten, Leon Reteig, Gonca E Karahan, Stefan P Berger, Jan-Stephan Sanders